← Back to Search

With LV Unloading for Cardiogenic Shock

Phase 2
Recruiting
Research Sponsored by University of Utah
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up hospital discharge up to 6 months
Awards & highlights

Study Summary

This trial aims to compare the use of a heart assist device called veno-arterial extracorporeal membrane oxygenation (VA ECMO) with or without an additional device to help the heart

Who is the study for?
This trial is for patients with non-postoperative cardiogenic shock, a severe heart condition where the heart can't pump enough blood. Participants must be receiving veno-arterial extracorporeal membrane oxygenation (VA ECMO) treatment.Check my eligibility
What is being tested?
The study compares two approaches: one group receives VA ECMO alone, while the other gets VA ECMO plus left ventricular unloading using an intra-aortic balloon pump (IABP). The effects on heart and lung function will be measured through lab tests, echocardiography, and pulmonary artery catheter data.See study design
What are the potential side effects?
Potential side effects include complications related to IABP like bleeding or vascular issues, infection risk from additional invasive procedures, and possible impact on organ function due to changes in circulatory support.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~hospital discharge up to 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and hospital discharge up to 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in pulmonary capillary wedge pressure
Secondary outcome measures
Cardiac BIN1
Change in N-terminal pro b-type natriuretic peptide
Change in left ventricular end diastolic diameter
+11 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: With LV UnloadingExperimental Treatment1 Intervention
Patients on VA ECMO who randomize to receive LV unloading
Group II: Without LV UnloadingActive Control1 Intervention
Patients on VA ECMO who randomize to receive no LV unloading
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
IABP
2009
N/A
~160

Find a Location

Who is running the clinical trial?

University of MinnesotaOTHER
1,381 Previous Clinical Trials
1,551,180 Total Patients Enrolled
University of UtahLead Sponsor
1,102 Previous Clinical Trials
1,779,157 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the recruitment phase of this clinical trial still ongoing?

"As per clinicaltrials.gov, this investigation is actively seeking eligible participants. Initial registration for the trial was on April 15th, 2024, with the most recent update conducted on March 27th of the same year."

Answered by AI

What is the safety profile of With LV Unloading in individuals?

"Our team at Power has rated the safety of With LV Unloading as 2 on a scale of 1 to 3. This is due to it being a Phase 2 trial, where some data supports safety but efficacy data is lacking."

Answered by AI

What is the current number of participants being recruited for this clinical study?

"Indeed, information on clinicaltrials.gov shows that this specific research study is actively seeking participants. The trial was originally listed on April 15, 2024, and the most recent update was made on March 27, 2024. There is a need to recruit a total of 104 patients from one designated site."

Answered by AI
~69 spots leftby Feb 2028